IOVA
Iovance Biotherapeutics Inc
13.00$
-8.4%
vs. previous close
Closing price · As of: Oct 6, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -1.6% | +2.0% | +9.7% | +2.6% | +4.8% | -5.3% | +7.9% | -2.2% | +53.0% | -57.5% | -12.8% | – | |
| – | -9.0% | +19.3% | +77.4% | +1.8% | -0.1% | -26.0% | -34.8% | -20.4% | -0.7% | -4.6% | +4.1% | – | |
| – | +101.8% | -373.8% | – | – | – | – | – | -192.9% | – | – | – | – | |
| – | -1.3% | +18.2% | -89.4% | +417.6% | +82.2% | +49.0% | +20.1% | +45.3% | -14.1% | -29.1% | -17.7% | – | |
| – | -7.8% | +53.1% | – | -221.3% | – | -33.0% | -12.8% | +22.9% | -95.4% | +1,370.2% | -749.9% | – | |
| – | -50.9% | +2,427.4% | -78.7% | – | – | – | – | – | -74.7% | – | – | – | |
| – | -99.5% | +20,022.2% | -21.1% | -72.5% | -94.5% | +6,106.8% | -90.8% | +565.6% | -36.2% | +67.9% | -47.8% | – | |
| – | -505.3% | – | – | -168.3% | – | – | -170.8% | – | -80.7% | -3,267.7% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.